{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T14:58:58Z","timestamp":1787237938598,"version":"build-2736575974"},"reference-count":10,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T00:00:00Z","timestamp":1775779200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["HIV Research & Clinical Practice"],"published-print":{"date-parts":[[2026,12,31]]},"DOI":"10.1080\/25787489.2026.2657707","type":"journal-article","created":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T04:00:33Z","timestamp":1775880033000},"update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":1,"title":["Successful initiation of fully parenteral antiretroviral therapy in a treatment-na\u00efve person with HIV-1 infection and intestinal failure"],"prefix":"10.1080","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-7944-0944","authenticated-orcid":false,"given":"Krystof","family":"Sram","sequence":"first","affiliation":[{"name":"Department of Infectious Diseases of 1, 2, and 3 Medical Faculties of Charles University in Prague and Bulovka University Hospital","place":["Prague 8, Czech Republic"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanus","family":"Rozsypal","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases of 1, 2, and 3 Medical Faculties of Charles University in Prague and Bulovka University Hospital","place":["Prague 8, Czech Republic"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanislav","family":"Sevela","sequence":"additional","affiliation":[{"name":"4Department of Internal Medicine \u2013 Department of Gastroenterology and Hepatology, First Faculty of Medicine, Charles University and General University Hospital in Prague (VFN)","place":["Prague 2, Czech Republic"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jakub","family":"Lhotan","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases of 1, 2, and 3 Medical Faculties of Charles University in Prague and Bulovka University Hospital","place":["Prague 8, Czech Republic"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Jilich","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases of 1, 2, and 3 Medical Faculties of Charles University in Prague and Bulovka University Hospital","place":["Prague 8, Czech Republic"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,4,10]]},"reference":[{"key":"e_1_3_5_2_1","volume-title":"EACS Guidelines: Version 13.0, 2025 \u2013 Treatment of People Living with HIV [Internet]","author":"European AIDS Clinical Society (EACS)","year":"2025","unstructured":"European AIDS Clinical Society (EACS). EACS Guidelines: Version 13.0, 2025 \u2013 Treatment of People Living with HIV [Internet]. Brussels: European AIDS Clinical Society; 2025 [cited 2025 Nov 9]. Available from: https:\/\/www.eacsociety.org\/guidelines\/version-13-0-2025\/"},{"key":"e_1_3_5_3_1","volume-title":"Retrovir (zidovudine) injection, for intravenous use \u2013 prescribing information [Internet]","author":"U.S. Food and Drug Administration","year":"2011","unstructured":"U.S. Food and Drug Administration. Retrovir (zidovudine) injection, for intravenous use \u2013 prescribing information [Internet]. Silver Spring (MD): U.S. Food and Drug Administration; 2011 [cited 2025 Nov 9]. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2011\/019951s029lbl.pdf"},{"key":"e_1_3_5_4_1","volume-title":"Vocabria (cabotegravir) injection and tablets \u2013 prescribing information [Internet]","author":"U.S. Food and Drug Administration","year":"2021","unstructured":"U.S. Food and Drug Administration. Vocabria (cabotegravir) injection and tablets \u2013 prescribing information [Internet]. Silver Spring (MD): U.S. Food and Drug Administration; 2021 [cited 2025 Nov 9]. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2021\/212887s004lbl.pdf"},{"key":"e_1_3_5_5_1","volume-title":"Rekambys (rilpivirine) \u2013 summary of product characteristics (EPAR product information) [Internet]","author":"European Medicines Agency","year":"2025","unstructured":"European Medicines Agency. Rekambys (rilpivirine) \u2013 summary of product characteristics (EPAR product information) [Internet]. Amsterdam: European Medicines Agency; 2025 [cited 2025 Nov 9]. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/rekambys-epar-product-information_en.pdf"},{"key":"e_1_3_5_6_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1909512"},{"key":"e_1_3_5_7_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1904398"},{"key":"e_1_3_5_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eimce.2024.07.003"},{"key":"e_1_3_5_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/hiv.70512"},{"key":"e_1_3_5_10_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000002883"},{"key":"e_1_3_5_11_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-025-04041-7"}],"container-title":["HIV Research & Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/25787489.2026.2657707","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T04:00:34Z","timestamp":1775880034000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/25787489.2026.2657707"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,10]]},"references-count":10,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12,31]]}},"alternative-id":["10.1080\/25787489.2026.2657707"],"URL":"https:\/\/doi.org\/10.1080\/25787489.2026.2657707","relation":{},"ISSN":["2578-7489","2578-7470"],"issn-type":[{"value":"2578-7489","type":"print"},{"value":"2578-7470","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,10]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=yhct21","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=yhct21","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2026-01-23","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-06","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-10","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"2657707"}}